Table 2 Predictors of progression-free survival in univariate and multivariate survival analysis
From: Comparative study of endometrioid borderline ovarian tumor with and without endometriosis
Characteristics | n | P(univariate analysis) | P(multivariate analysis) | P(stratified analysis) | |
|---|---|---|---|---|---|
Age | < 50 years | 41(78.8%) | 0.031 | 1.000 | 0.733 |
≥50 years | 11(21.2%) | – | |||
Nulliparous | No | 28(53.8%) | 0.548 | – | 0.045 |
Yes | 24(46.2%) | 0.315 | |||
Gravidity | ≤2 | 36(70.6%) | 0.746 | – | 0.492 |
> 2 | 15(29.4%) | 0.536 | |||
Menopause | No | 40(76.9%) | 0.023 | 0.983 | 0.834 |
Yes | 12(23.1%) | – | |||
CA125 | < 35 U/ml | 15(31.3%) | 0.893 | – | 0.336 |
≥35 U/ml | 33(68.7%) | 0.103 | |||
CA125 | < 140 U/ml | 33(68.7%) | 0.019 | 0.344 | 0.301 |
≥140 U/ml | 15(31.3%) | 0.045 | |||
Maximal tumor diameter | < 10 cm | 40(80.0%) | 0.040 | 0.265 | 0.292 |
≥10 cm | 10(20.0%) | 0.077 | |||
Surgical approach | Laparoscopy | 22(42.3%) | 0.890 | – | 0.480 |
Laparotomy | 30(57.7%) | 0.120 | |||
Comprehensive staging surgery | No | 23(44.2%) | 0.824 | ||
Yes | 29(55.8%) | 0.586 | – | 0.108 | |
Fertility sparing surgery | No | 27(51.9%) | 0.697 | – | 0.019 |
Yes | 25(48.1%) | 0.272 | |||
Cyst rupture | No | 12(24.0%) | 0.055 | – | – |
Yes | 38(76.0%) | 0.517 | |||
FIGO stage | I | 49(94.2%) | 0.651 | – | 0.282 |
II、III、IV | 3(5.8%) | – | |||
Chemotherapy after surgery | No | 40(76.9%) | 0.387 | – | 0.851 |
Yes | 12(23.1%) | 0.441 | |||
Endometrial pathology | Without EIN/EC | 33(63.5%) | 0.830 | – | 0.122 |
EIN | 8(15.4%) | – | |||
EC | 11(21.2%) | 0.371 | |||
Tumor side | Unilateral | 47(90.4%) | 0.076 | – | 0.121 |
Bilateral | 5(9.6%) | – | |||
Endometriosis | No | 33(63.5%) | 0.315 | – | – |
Yes | 19(36.5%) | – |